SEC Form 4 · accession 0001437749-16-024799
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Khursheed Anwer
Officer — Chief Scientific Officer
Period of report
Feb 2, 2016
Accepted (ET)
Feb 4, 2016 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $1.33 | Feb 2, 2016 | A | 40,000 | A | Feb 2, 2016 | Feb 2, 2026 | Celsion Corporation Common Stock | 40,000 | 152,500 | D |
Explanation of responses
- F1Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F2The option vests in thirds on February 2, 2016, February 2, 2017 and February 2, 2018.